Financhill
Sell
49

VTRS Quote, Financials, Valuation and Earnings

Last price:
$15.0100
Seasonality move :
2.31%
Day range:
$15.1400 - $16.4700
52-week range:
$6.8500 - $16.4700
Dividend yield:
3.15%
P/E ratio:
--
P/S ratio:
1.28x
P/B ratio:
1.15x
Volume:
18.7M
Avg. volume:
9.9M
1-year change:
35.68%
Market cap:
$17.6B
Revenue:
$14.7B
EPS (TTM):
-$3.10

Analysts' Opinion

  • Consensus Rating
    Viatris, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $14.4444, Viatris, Inc. has an estimated downside of -7.47% from its current price of $15.2500.
  • Price Target Upside
    According to analysts, the highest upside price target is $18.0000 representing 18.03% upside increase from its current price of $15.2500.

Fair Value

  • According to the consensus of 9 analysts, Viatris, Inc. has -7.47% downside to fair value with a price target of $14.4444 per share.

VTRS vs. S&P 500

  • Over the past 5 trading days, Viatris, Inc. has underperformed the S&P 500 by -4.56% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Viatris, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Viatris, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Viatris, Inc. reported revenues of $3.8B.

Earnings Growth

  • Viatris, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viatris, Inc. reported earnings per share of -$0.11.
Enterprise value:
31.2B
EV / Invested capital:
--
Price / LTM sales:
1.28x
EV / EBIT:
30.89x
EV / Revenue:
2.22x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
19.32x
Price / Operating cash flow:
11.16x
Enterprise value / EBITDA:
8.23x
Gross Profit (TTM):
$5.3B
Return On Assets:
-9.18%
Net Income Margin (TTM):
-26.25%
Return On Equity:
-21.75%
Return On Invested Capital:
-11.6%
Operating Margin:
8.44%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $15.4B $15B $14.1B $3.8B $3.8B
Gross Profit $6.4B $6.1B $5.3B $1.6B $1.4B
Operating Income $2.1B $1.4B $1B $489.7M $317.4M
EBITDA $5B $4.2B $3.8B $1.2B $1B
Diluted EPS $1.51 -$0.74 -$3.10 $0.08 -$0.11
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $11.3B $10.5B $10.9B $10.7B $9.3B
Total Assets $56.1B $48.7B $48.7B $44.8B $37.9B
Current Liabilities $10.1B $6.5B $6.8B $7.5B $7.4B
Total Liabilities $34.9B $29.5B $27.9B $25B $22.7B
Total Equity $21.1B $19.2B $20.9B $19.8B $15.2B
Total Debt $22B $19.7B $18.5B $15.9B $14.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2.5B $2.3B $2B $826.5M $744.9M
Cash From Investing $904.6M $2.1B -$385.2M $1.7B -$98.9M
Cash From Financing -$2.7B -$3.8B -$2.5B -$1.6B -$228.1M
Free Cash Flow $2B $1.9B $1.6B $741.1M $645.2M
VTRS
Sector
Market Cap
$17.6B
$25.8M
Price % of 52-Week High
92.59%
50.24%
Dividend Yield
3.15%
0%
Shareholder Yield
13.08%
-1.64%
1-Year Price Total Return
35.68%
-18.88%
Beta (5-Year)
0.788
0.496
Dividend yield:
3.15%
Annualized payout:
$0.48
Payout ratio:
16.42%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $15.8794
200-day SMA
Buy
Level $10.7328
Bollinger Bands (100)
Buy
Level 10.1573 - 13.9373
Chaikin Money Flow
Sell
Level -12M
20-day SMA
Buy
Level $15.1518
Relative Strength Index (RSI14)
Buy
Level 57.5389
ADX Line
Sell
Level 34.802
Williams %R
Neutral
Level -51.4768
50-day SMA
Buy
Level $13.5809
MACD (12, 26)
Buy
Level 4.3116
25-day Aroon Oscillator
Buy
Level 72
On Balance Volume
Neutral
Level 10.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.1006)
Sell
CA Score (Annual)
Level (-0.4306)
Buy
Beneish M-Score (Annual)
Level (-2.8252)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.3077)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Stock Forecast FAQ

In the current month, VTRS has received 5 Buy ratings 4 Hold ratings, and 0 Sell ratings. The VTRS average analyst price target in the past 3 months is $14.4444.

  • Where Will Viatris, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Viatris, Inc. share price will drop to $14.4444 per share over the next 12 months.

  • What Do Analysts Say About Viatris, Inc.?

    Analysts are divided on their view about Viatris, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viatris, Inc. is a Sell and believe this share price will rise from its current level to $12.0000.

  • What Is Viatris, Inc.'s Price Target?

    The price target for Viatris, Inc. over the next 1-year time period is forecast to be $14.4444 according to 9 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is VTRS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Viatris, Inc. is a Buy. 5 of 9 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of VTRS?

    You can purchase shares of Viatris, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viatris, Inc. shares.

  • What Is The Viatris, Inc. Share Price Today?

    Viatris, Inc. was last trading at $15.0100 per share. This represents the most recent stock quote for Viatris, Inc.. Yesterday, Viatris, Inc. closed at $15.2500 per share.

  • How To Buy Viatris, Inc. Stock Online?

    In order to purchase Viatris, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 14.44% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 9.54% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 5.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock